S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Closing prices for crude oil, gold and other commodities
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
MarketBeat Week in Review – 3/27 - 3/31
UN body mulls deep sea mining amid demand for minerals
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Buy THIS stock before Taiwan is attacked (Ad)
Canada approves largest telecom deal in country's history
Medicare, Social Security could fall short over next decade
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Closing prices for crude oil, gold and other commodities
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
MarketBeat Week in Review – 3/27 - 3/31
UN body mulls deep sea mining amid demand for minerals
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Buy THIS stock before Taiwan is attacked (Ad)
Canada approves largest telecom deal in country's history
Medicare, Social Security could fall short over next decade
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Closing prices for crude oil, gold and other commodities
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
MarketBeat Week in Review – 3/27 - 3/31
UN body mulls deep sea mining amid demand for minerals
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Buy THIS stock before Taiwan is attacked (Ad)
Canada approves largest telecom deal in country's history
Medicare, Social Security could fall short over next decade
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Closing prices for crude oil, gold and other commodities
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
MarketBeat Week in Review – 3/27 - 3/31
UN body mulls deep sea mining amid demand for minerals
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Buy THIS stock before Taiwan is attacked (Ad)
Canada approves largest telecom deal in country's history
Medicare, Social Security could fall short over next decade
NASDAQ:ATEC

Alphatec - ATEC Stock Forecast, Price & News

$15.60
-0.19 (-1.20%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$15.48
$16.19
50-Day Range
$12.74
$16.02
52-Week Range
$5.73
$16.34
Volume
1.32 million shs
Average Volume
1.03 million shs
Market Capitalization
$1.73 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.25

Alphatec MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
4.2% Upside
$16.25 Price Target
Short Interest
Bearish
10.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
0.67mentions of Alphatec in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$969.63 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.04) to ($0.74) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.72 out of 5 stars

Medical Sector

871st out of 1,004 stocks

Surgical & Medical Instruments Industry

91st out of 104 stocks


ATEC stock logo

About Alphatec (NASDAQ:ATEC) Stock

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Stock News Headlines

Alphatec (NASDAQ:ATEC) Upgraded by StockNews.com to Hold
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
ATEC Advances Lateral Sophistication
See More Headlines
Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Company Calendar

Last Earnings
11/04/2021
Today
4/01/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ATEC
CUSIP
02081G10
Employees
561
Year Founded
1990

Price Target and Rating

Average Stock Price Forecast
$16.25
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$9.50
Forecasted Upside/Downside
+4.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-152,150,000.00
Pretax Margin
-43.32%

Debt

Sales & Book Value

Annual Sales
$350.87 million
Book Value
($0.35) per share

Miscellaneous

Free Float
73,410,000
Market Cap
$1.73 billion
Optionable
Not Optionable
Beta
1.25

Social Links


Key Executives

  • Patrick S. MilesPatrick S. Miles
    Chairman, President, CEO & COO
  • J. Todd Koning
    Chief Financial Officer & Executive Vice President
  • Kelli M. Howell
    Executive Vice President-Clinical Strategies
  • Luiz Pimenta
    Chief Medical Officer
  • Scott LishScott Lish
    Senior Vice President-Research & Development













ATEC Stock - Frequently Asked Questions

Should I buy or sell Alphatec stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ATEC shares.
View ATEC analyst ratings
or view top-rated stocks.

What is Alphatec's stock price forecast for 2023?

6 analysts have issued twelve-month price objectives for Alphatec's shares. Their ATEC share price forecasts range from $9.50 to $20.00. On average, they predict the company's share price to reach $16.25 in the next year. This suggests a possible upside of 4.2% from the stock's current price.
View analysts price targets for ATEC
or view top-rated stocks among Wall Street analysts.

How have ATEC shares performed in 2023?

Alphatec's stock was trading at $12.35 at the beginning of the year. Since then, ATEC stock has increased by 26.3% and is now trading at $15.60.
View the best growth stocks for 2023 here
.

Are investors shorting Alphatec?

Alphatec saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 6,700,000 shares, an increase of 9.3% from the February 28th total of 6,130,000 shares. Based on an average daily volume of 982,400 shares, the days-to-cover ratio is presently 6.8 days. Currently, 10.6% of the company's stock are short sold.
View Alphatec's Short Interest
.

When is Alphatec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our ATEC earnings forecast
.

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) released its earnings results on Thursday, November, 4th. The medical technology company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.23) by $0.20. The medical technology company earned $62.88 million during the quarter, compared to analyst estimates of $61.43 million. Alphatec had a negative net margin of 43.36% and a negative trailing twelve-month return on equity of 575.45%. During the same quarter in the prior year, the firm earned ($0.18) EPS.

What guidance has Alphatec issued on next quarter's earnings?

Alphatec updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $438.00 million-$438.00 million, compared to the consensus revenue estimate of $426.30 million.

What is Pat Miles' approval rating as Alphatec's CEO?

19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.

What other stocks do shareholders of Alphatec own?
What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

How do I buy shares of Alphatec?

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $15.60.

How much money does Alphatec make?

Alphatec (NASDAQ:ATEC) has a market capitalization of $1.73 billion and generates $350.87 million in revenue each year. The medical technology company earns $-152,150,000.00 in net income (profit) each year or ($1.47) on an earnings per share basis.

How many employees does Alphatec have?

The company employs 561 workers across the globe.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The official website for the company is www.atecspine.com. The medical technology company can be reached via phone at (760) 431-9286, via email at ir@alphatecspine.com, or via fax at 800-922-1356.

This page (NASDAQ:ATEC) was last updated on 4/1/2023 by MarketBeat.com Staff